orofacial pain

Merck loses retrial of Fosamax/ONJ case

Merck has been ordered to pay $8 million in compensatory damages to a 72-year-old woman who claimed the company’s bisphosphonate drug Fosamax caused her to

Merck triumphs in 2nd Fosamax trial

A federal court jury in New York has found in favor of Merck in the second trial involving the pharmaceutical company’s Fosamax bisphosphonate drug. The

Is articaine better for infiltrations?

Articaine worked better than competing anesthetics in seven out of 10 randomized clinical trials of infiltration analyzed for a review presented at the recent American

WhatsApp